﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Medical Journal of Tabriz University of Medical Sciences</JournalTitle>
      <Issn>2783-2031</Issn>
      <Volume>34</Volume>
      <Issue>5</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2013</Year>
        <Month>01</Month>
        <DAY>28</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Serum Asymmetric Dimethylarginine (ADMA) Levels in Exudative Age-Related Macular Degeneration (E-ARMD)</ArticleTitle>
    <FirstPage>19</FirstPage>
    <LastPage>23</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>Alireza Javadzadeh</LastName>
      </Author>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>Amir Ghorbanihaghjo</LastName>
      </Author>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>Sima Manzori</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2013</Year>
        <Month>01</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <Abstract>Background and Objectives: Exudative Age Related Macular degeneration (E-ARMD) is a multifactorial disease. The aim of the present study was to investigate the plasma levels of asymmetric dimethylarginine (ADMA) as a factor involved in oxidative stress in patients with E-ARMD. Materials and Methods: In a case-control study, 45 patients with E-ARMD were compared with 45 sex- and age- matched healthy controls. The plasma levels of ADMA were measured by Enzyme-Linked ImmunoSorbant Assay (ELISA) method in both groups. Results: The levels of ADMA were higher in patients with E-ARMD (0.84±0.23 μM) than normal controls (0.71±0.25 μM) and the difference was statistically significant (p=0.012). Conclusion: High levels of ADMA as an endogenous nitric oxide synthase inhibitors may have a role in oxidative stress in E-ARMD patients.</Abstract>
  </Article>
</ArticleSet>